Therefore, the notion of significantly elevated CRP levels in the non-prior rhGH group may not only explain the higher frequency of anemia as a consequence of inflammation but also subclinical graft rejection in these patients which may contribute to the inferior long-term graft function. The gene discussed is CRP; the disease is anemia.